newsfilter
← Latest News
GlobeNewswire·

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; Full Operational Capacity Expected by Year-End 2025 Balance